Background illustration for clinical trials search

Cardiovascular Clinical Trials

Browse 3,486 Cardiovascular clinical trials enrolling across the United States and Canada. 275 people applied to Cardiovascular studies last month. Search by city or state to find one near you.

Filter
1

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: Halifax, Sherbrooke, New York NY, Montreal, Camden NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase 2, Recruiting

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

for
Cardiac Rehabilitation, Heart Disease
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07214350

Recruiting

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

for
Retinopathy, Retinal Vein Occlusion, Diabetic Retinopathy,
Location: Ann Arbor MI
Sponsor: MediBeacon

Sex: All

Age: 18+

Code: NCT04008121

Early Phase 1, Recruiting

The HEARTFELT Study

for
Heart Failure, Chronic Heart Failure
Location: Hackensack NJ, Bala-Cynwyd PA
Sponsor: Heartfelt Technologies

Sex: All

Age: 22+

Code: NCT06222099

Recruiting

Sisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker Women

for
Occupational Stress, Gender Related Stress, Social Isolation,
Location: Ellenton GA
Sponsor: Emory University

Sex: Female

Age: 18 - 50

Code: NCT07111026

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

for
Tetraplegia/Tetraparesis, Quadriplegia,
Location: Dallas TX
Sponsor: Neuralink Corp

Sex: All

Age: 22 - 70+

Code: NCT07224256

Recruiting

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

for
Coronary Arterial Disease (CAD),
Location: Jacksonville FL
Sponsor: University of Florida

Sex: All

Age: 18+

Code: NCT07025148

Recruiting

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

for
Intermittent Claudication
Location: Pittsburgh PA
Sponsor: VA Office of Research and Development

Sex: All

Age: 35 - 70+

Code: NCT05132439

Phase 3, Recruiting

Paired-Ring Mitral Annuloplasty Ring Sizing Device

for
Heart Valve Diseases
Location: Glenview IL
Sponsor: Endeavor Health

Sex: All

Age: 18+

Code: NCT06965725

Recruiting

FT839 in Autoimmune Diseases

for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07800871

Phase 1, Phase 2, Recruiting

Effect of Electro-Acupuncture on Blood Pressure

for
Hypertension
Location: Orange CA, Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 18 - 70+

Code: NCT00932139

Recruiting

SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure

for
Congenital Heart Disease
Location: Toronto, Vancouver
Sponsor: Subodh Verma

Sex: All

Age: 18+

Code: NCT06955260

Phase 3, Recruiting

Serranator Recoil Study

for
Peripheral Arterial Disease, Critical Limb Ischemia
Location: Palo Alto CA
Sponsor: Cagent Vascular LLC

Sex: All

Age: 18+

Code: NCT05161039

Recruiting

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy (DCM)
Location: Boston MA, Washington D.C. DC, Columbus OH,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07771465

Phase 3, Recruiting

Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH

for
Social Determinants of Health (SDOH), Hypertension,
Location: Tucson AZ
Sponsor: Sairam Parthasarathy

Sex: All

Age: 18+

Code: NCT07799961

Recruiting

Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU

for
Diabetic Foot Ulcers (DFUs)
Location: Miami Beach FL, Margate FL, Plantation FL, Doral FL,
Sponsor: Lakewood-Amedex Inc

Sex: All

Age: 18+

Code: NCT07565506

Phase 2, Recruiting

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase 2, Recruiting

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

for
Atrial Fibrillation, Hemostasis
Location: Independence MO, Kansas City MO, Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 18+

Code: NCT06078735

Recruiting

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

for
Uncontrolled Hypertension
Location: Boston MA, Methuen MA, Waterbury CT, The Bronx NY,
Sponsor: Retension Pharmaceuticals. Inc.

Sex: All

Age: 18 - 70+

Code: NCT07142356

Phase 2, Recruiting

Exenatide for Myocardial Protection During Reperfusion Study

for
Myocardial Infarction
Location: Quebec City, Toronto, Newmarket, Hamilton, London,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT01938235

Phase 2, Recruiting

What is cardiovascular disease?

Cardiovascular disease is the group of conditions that affect the heart and blood vessels, and together they are the leading cause of death in the United States. The most common is coronary artery disease, in which cholesterol filled plaque narrows the arteries that feed the heart and can cause a heart attack. Others include heart failure, where the heart cannot pump well enough; rhythm problems such as atrial fibrillation; stroke, when blood flow to the brain is blocked; and disease of the heart valves and peripheral arteries. High blood pressure, high cholesterol, diabetes, smoking, obesity, and inactivity drive most of it.

Much of cardiovascular disease can be prevented or slowed, and nearly every tool doctors use came from large trials that measured real heart attacks, strokes, and deaths rather than lab numbers. One frontier is lipoprotein(a), an inherited cholesterol like particle that is high in about 1 in 5 people and cannot be lowered by diet, exercise, or any approved medicine; large outcome trials of drugs that target it are under way.

Types of cardiovascular clinical trials

Who can participate in cardiovascular clinical trials?

How is cardiovascular disease prevented?

Types of cardiovascular disease, and where to find their trials

How to enroll in a cardiovascular clinical trial